NPI registry status
Active
2026 NPPES data Allergy & Immunology (Internal Medicine) Physician NPI 1295359172
Verify on CMS → Michelle Manious
Allergy & Immunology (Internal Medicine) Physician in Boston, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 528 in Allergy & Immunology (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
42
Medicare Part D claims · 13 beneficiaries · Allergy & Immunology (Internal Medicine) Physician avg: 835
Generic prescribing
69%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$165.34
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michelle Manious filed 42 Medicare Part D claims in 2024 as an Allergy & Immunology (Internal Medicine) Physician in Boston, Massachusetts, prescribing 69% generic.
- 42
- Part D claims, 2024
- 69%
- generic prescribing
- $165.34
- industry payments (Sunshine Act)
- ≥0th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michelle Manious
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1295359172), first enumerated 06/05/2020.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 42 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$165.34 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Michelle Manious's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1295359172 · Allergy & Immunology (Internal Medicine) Physician
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-TRACE · BOOK-THIN · PHOTO-ENUM
- NPI-10 1295359172
- ENUM-RECENT 2020
- TAX-NARROW 528
- RX-TRACE 42
- BOOK-THIN 19 in Massachusetts
- PHOTO-ENUM Arundhati Chandini A… · 2020
Michelle Manious's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
42 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Michelle Manious practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michelle Manious?
Quality data not reportedPrimary specialty
Allergy & Immunology (Internal Medicine) Physician
Medicare Part D claims
42 95% vs specialty avg
Specialty distribution in Massachusetts
How Allergy & Immunology (Internal Medicine) Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Allergy & Immunology (Internal Medicine) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1295359172 |
|---|---|
| Specialty | Allergy & Immunology (Internal Medicine) Physician |
| Gender | Female |
| NPI Issued | 06/05/2020 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michelle Manious. Source: openpaymentsdata.cms.gov.
Total received
$165
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Michelle Manious. To verify Michelle Manious's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Michelle Manious - brand share 31.0%
Allergy & Immunology (Internal Medicine) Physician average
31% brand-name claims vs 69% generic, on 42 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
42
Total Claims
$10K
Total Drug Cost
13
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 63.967
- Total Day Supply
- 1,781
- Brand vs Generic
- 31% brand / 69% generic
- Brand Drug Cost
- $9K
- Generic Drug Cost
- $588
Patient Demographics
- Average Patient Age
- 58.5 years
- Avg HCC Risk Score
- 1.32
More Allergy & Immunology (Internal Medicine) Physician in MA →
All providers in Massachusetts →
Compare specialties →
Allergy & Immunology (Internal Medicine) Physician Overview
How Michelle Manious fits within the Allergy & Immunology (Internal Medicine) Physician landscape nationally.
528
Allergy & Immunology (Internal Medicine) Physician Providers in US
47
States with Allergy & Immunology (Internal Medicine) Physician
835
Avg Claims per Provider
Michelle Manious's 42 claims are below the specialty average of 835.
Nationwide Allergy & Immunology (Internal Medicine) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Manious, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2020)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Allergy & Immunology (Internal Medicine) Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Manious.
One of 19 Allergy & Immunology (Internal Medicine) Physician providers enrolled in Massachusetts, 5 are shown here.
Frequently Asked Questions
What is Michelle Manious's specialty? ▼
Michelle Manious specializes in Allergy & Immunology (Internal Medicine) Physician and practices in Boston, Massachusetts.
How much does Michelle Manious prescribe under Medicare Part D? ▼
In 2024, Michelle Manious wrote 42 Medicare Part D claims totaling $10K in drug costs for 13 beneficiaries.
Where is Michelle Manious located? ▼
Michelle Manious is located at 300 LONGWOOD AVE, Boston, MA, 02115. Phone: (617) 355-6000.
What is Michelle Manious's NPI number? ▼
Michelle Manious's National Provider Identifier (NPI) is 1295359172, issued on 06/05/2020.
Does Michelle Manious prescribe more brand-name or generic drugs? ▼
Michelle Manious's prescribing is 31% brand-name and 69% generic drugs by claim count, with $9K in brand drug costs.
How many Allergy & Immunology (Internal Medicine) Physician providers are there in the US? ▼
There are 528 Allergy & Immunology (Internal Medicine) Physician providers across 47 states in the US. The average Allergy & Immunology (Internal Medicine) Physician provider writes 835 Medicare Part D claims per year.
Does Michelle Manious accept Medicare? ▼
Michelle Manious appears in CMS Medicare data with 42 Part D claims and 13 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michelle Manious's credentials? ▼
Michelle Manious's NPI is 1295359172. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.